Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP-Reference-Cited by-同舟云学术

Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP

Published:2016-07-02 Issue:6 Volume:42 Page:322-333
ISSN:0190-2148
Container-title:Experimental Lung Research
language:en
Short-container-title:Experimental Lung Research

Author:

Li Hong-tao¹,Chen Zhuang-gui²,Liu Hui¹,Ye Jin³,Zou Xiao-ling¹,Wang Yan-hong¹,Yang Hai-ling¹,Meng Ping¹,Zhang Tian-tuo¹

Affiliation:

1. Department of Pulmonary Diseases, Institute of Respiratory Diseases of Sun Yat-sen University, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

2. Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

3. Department of Otolaryngology, Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01902148.2016.1215571

Reference53 articles.

1. Allergic rhinitis is associated with poor asthma control in children with asthma

2. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis

3. The connection between allergic rhinitis and bronchial asthma